Graham Corporation reports again today — this time from a very different starting point than a week ago, with the stock up 21% on the week to $115.89 and shorts who added through the June 8 dip now sitting on meaningful losses.
The rally has reshaped the setup entirely. Where the pre-June 8 preview described a stock under pressure with hedging demand spiking, the picture now is a stock that absorbed the selloff, bounced hard, and carried most of its short-side opposition with it. Short interest edged down fractionally on June 16 to 4.3% of the free float — still the highest level seen over the past month, and up roughly 49% over that window — meaning bears who added on the dip have not yet covered. The borrow market remains extremely loose, with availability at 1,314%: thirteen shares available for every one already shorted. Cost to borrow is negligible at 0.49%. There is no mechanical squeeze pressure here, but the shorts are offside on price. Options positioning has eased from the four-standard-deviation spike seen heading into June 8 — the put/call ratio is now 0.23, about one standard deviation above its 20-day mean of 0.18 — cautious relative to the norm but nowhere near panic hedging.
The analyst community is playing catch-up with the move. Oppenheimer raised its target to $110 on June 9 — just after the prior print — maintaining its Outperform rating. At $115.89, the stock has already traded through that revised target. The mean consensus target of $112.75 now sits below the current price, meaning the Street's published numbers collectively lag the tape. The forward earnings multiple has expanded sharply: the PE ratio has climbed roughly 12 points over the past month to 56x, and EV/EBITDA is running near 30x. Factor scores capture the tension — the 90-day forward EPS estimate growth ranks in the 98th percentile of the universe, a powerful fundamental tailwind, while the EV/EBIT factor ranks in just the 4th percentile, signalling stretched valuation on an absolute basis. Bulls are leaning on the defense spending cycle and an order backlog that drove 18% revenue growth last quarter. Bears are pointing at a multiple that has re-rated aggressively into that narrative.
The insider activity adds a layer of complexity. On June 8 — the day of the initial selloff — CEO Daniel Thoren sold 8,095 shares at $95.34 for roughly $772k, and CFO Christopher Thome sold 3,193 shares at the same price for $304k. Both also received stock awards that day. The net 90-day insider position is positive at roughly 20,500 shares, largely reflecting those awards rather than open-market buying. The sells came at the low and look more like award-related transactions than conviction selling, but the timing is notable heading into today's print.
Today's report is therefore less about whether Graham is growing — the backlog and revenue trend have made that case — and more about whether management's guidance and margin commentary can justify a valuation that has now run well ahead of where the Street's price targets landed just nine days ago.
See the live data behind this article on ORTEX.
Open GHM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
